Increase in PTP1B expression or activity provides a mechanistic explanation for insulin resistance in the brain and metabolically active tissues (adipose tissue, liver, muscle, and hypothalamus) [3–5, 15–17] in situations of metabolic disorders such as obesity and diabetes. Here, PTPN1 is linked to metabolic disease.